Read While You Wait - Get immediate ebook access, if available*, when you order a print book

Communicating about Risks and Safe Use of Medicines

Real Life and Applied Research

Editors: Bahri, Priya (Ed.)

Free Preview
  • Proposes a multilayered approach to medicinal product risk communication research for increasingly emerging collaborations between disciplines and parties aiming at understanding, planning and evaluating communication for improved health outcomes
  • Presents a wide range of research methods in accessible language, underpinned by overviews on communication types and outcomes in practical tables and illustrated by examples and case studies of real life experiences of safety concerns with medicines
  • Written by internationally experienced authors for a global readership of researchers, practitioners, students and patient advocates active in communications, healthcare, the social sciences and pharmacovigilance
see more benefits

Buy this book

eBook 93,08 €
price for Spain (gross)
  • ISBN 978-981-15-3013-5
  • Digitally watermarked, DRM-free
  • Included format: EPUB, PDF
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Hardcover 114,39 €
price for Spain (gross)
  • ISBN 978-981-15-3012-8
  • Free shipping for individuals worldwide
  • Immediate ebook access, if available*, with your print order
  • Usually dispatched within 3 to 5 business days.
  • The final prices may differ from the prices shown due to specifics of VAT rules
About this book

At the core of this book lies the question how to approach medicines, risks and communication as a researcher - or anybody planning and evaluating a communication intervention, or wanting to understand communication events in private and the media. With a view to tackle current shortcomings of communication systems and processes for improved implementation, patient satisfaction and health outcomes, a multilayered approach is presented. This combines multiple data types and methods to obtain a wider and deeper understanding of the major parties and their interactions, as well as the healthcare, social and political contexts of information flows, how they interfere and which impact they have. Illustrated with real life experiences of safety concerns with medicines, worldwide active experts discuss the methods and contributions their disciplines can offer. With considerations on terminologies, tabulated overviews on communication types and outcomes, a patient-centred vision and plain language for non-medical readers, the book creates a platform for multidisciplinary collaborations amongst researchers as well as practitioners from communications, healthcare, the social sciences and pharmacovigilance. Importantly, it advocates for an active role of patients and highlights the achievements and aspirations of patient organisations. Finally, the book suggests establishing an inclusive discipline of humanities and epidemiology of medicinal product risk communication to realise full research potential. The authors are driven by the curiosity for communication as the most human behaviour, and as good health is amongst the basic human needs, medicinal product risk communication is an exciting research field of high global relevance.

About the authors

Priya Bahri holds degrees in pharmacy and epidemiology, focused her PhD at Humboldt University of Berlin on healthcare quality management, and is trained in strategic communication and global health diplomacy. She worked in pharmacies and for projects of health insurance physicians’ associations and the German international development agency before joining the European Medicines Agency (EMA) in 1996 and specialising in pharmacovigilance. She is active for the Utrecht WHO Collaborating Centre for Pharmaceutical Policy and Regulation and also in learned societies, including as fellow of the International Society of Pharmacovigilance.

Table of contents (16 chapters)

Table of contents (16 chapters)
  • A Multilayered Research Framework for Humanities and Epidemiology of Medicinal Product Risk Communication

    Pages 1-84

    Bahri, Priya

  • Hormonal Contraceptives: Communication for Risk Awareness and Informed Choice, or a Public Scare?

    Pages 87-129

    Mintzes, Barbara (et al.)

  • COX-2 Inhibitors: Communication of Accumulating Risk Evidence and a Product Withdrawal

    Pages 131-146

    Rogers, Amy (et al.)

  • Isotretinoin: Communication for Preventing Birth Defects and Alerting of an Uncertain Risk of Suicide

    Pages 147-162

    Crijns, Ineke

  • Pandemic Influenza Vaccines: Communication of Benefits, Risks, and Uncertainties

    Pages 163-178

    Nowak, Glen J. (et al.)

Buy this book

eBook 93,08 €
price for Spain (gross)
  • ISBN 978-981-15-3013-5
  • Digitally watermarked, DRM-free
  • Included format: EPUB, PDF
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Hardcover 114,39 €
price for Spain (gross)
  • ISBN 978-981-15-3012-8
  • Free shipping for individuals worldwide
  • Immediate ebook access, if available*, with your print order
  • Usually dispatched within 3 to 5 business days.
  • The final prices may differ from the prices shown due to specifics of VAT rules
Loading...

Recommended for you

Loading...

Bibliographic Information

Bibliographic Information
Book Title
Communicating about Risks and Safe Use of Medicines
Book Subtitle
Real Life and Applied Research
Editors
  • Priya Bahri
Copyright
2020
Publisher
ADIS
Copyright Holder
Springer Nature Singapore Pte Ltd.
eBook ISBN
978-981-15-3013-5
DOI
10.1007/978-981-15-3013-5
Hardcover ISBN
978-981-15-3012-8
Edition Number
1
Number of Pages
XXX, 504
Number of Illustrations
2 b/w illustrations, 30 illustrations in colour
Topics

*immediately available upon purchase as print book shipments may be delayed due to the COVID-19 crisis. ebook access is temporary and does not include ownership of the ebook. Only valid for books with an ebook version. Springer Reference Works and instructor copies are not included.